Loading…
Privi Speciality Chemicals (PRIVISCL)₹3,492+1.18%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Privi Speciality Chemicals reported sales of ₹758 Cr, up 11.8% from Sep 2025, and net profit of ₹118 Cr, up 31.1% year on year. For the year to Mar 2026, sales were ₹2,555 Cr and net profit ₹317 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 403 | 483 | 462 | 532 | 490 | 612 | 558 | 678 | 603 | 720 | 665 | 758 |
| Expenses | 314 | 393 | 370 | 423 | 378 | 481 | 427 | 497 | 453 | 541 | 514 | 561 |
| Operating Profit | 90.08 | 91.03 | 94.01 | 110 | 113 | 133 | 132 | 182 | 151 | 180 | 152 | 200 |
| OPM % | 22.0% | 19.0% | 20.0% | 21.0% | 23.0% | 22.0% | 24.0% | 27.0% | 25.0% | 25.0% | 23.0% | 26.0% |
| Other Income | 5.98 | 7.97 | 2.99 | 3.99 | 1.99 | 14.95 | 8.98 | 0.00 | 6.98 | 3.99 | 14.95 | 12.97 |
| Interest | 24.03 | 25.02 | 22.04 | 22.02 | 22.03 | 23.03 | 24.04 | 21.03 | 19.04 | 18.02 | 17.02 | 17.03 |
| Depreciation | 32.09 | 30.09 | 32.07 | 32.10 | 32.08 | 35.11 | 36.08 | 36.08 | 36.06 | 36.09 | 37.09 | 37.10 |
| Profit before tax | 39.14 | 44.20 | 43.19 | 61.21 | 61.26 | 90.28 | 81.37 | 125 | 104 | 131 | 113 | 160 |
| Tax % | 26.1% | 28.1% | 27.1% | 26.1% | 27.1% | 29.1% | 29.1% | 28.1% | 28.1% | 27.1% | 27.1% | 26.1% |
| Net Profit | 29.01 | 32.01 | 30.99 | 45.03 | 44.01 | 64.04 | 57.98 | 90.05 | 74.97 | 94.03 | 83.05 | 118 |
| EPS (Rs) | 7.34 | 7.91 | 8.00 | 11.38 | 11.34 | 16.97 | 15.81 | 23.97 | 19.90 | 23.88 | 21.47 | 29.86 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 596 | 1,022 | 1,338 | 1,628 | 1,274 | 1,401 | 1,604 | 1,748 | 2,094 | 2,555 | 2,745 |
| Expenses | 525 | 893 | 1,127 | 1,362 | 1,066 | 1,209 | 1,419 | 1,422 | 1,643 | 1,912 | 2,068 |
| Operating Profit | 72.06 | 130 | 213 | 268 | 210 | 195 | 188 | 329 | 459 | 651 | 683 |
| OPM % | 12.0% | 13.0% | 16.0% | 16.0% | 16.0% | 14.0% | 12.0% | 19.0% | 22.0% | 25.0% | 24.9% |
| Other Income | 9.97 | 15.94 | 13.95 | 65.81 | 42.83 | 37.86 | 20.94 | 25.91 | 19.93 | 18.95 | 38.89 |
| Interest | 20.02 | 24.05 | 29.05 | 41.05 | 24.05 | 25.02 | 70.14 | 102 | 92.13 | 87.10 | 71.11 |
| Depreciation | 27.08 | 43.11 | 47.12 | 63.15 | 71.20 | 75.23 | 108 | 123 | 132 | 144 | 146 |
| Profit before tax | 36.14 | 79.32 | 153 | 232 | 159 | 133 | 31.12 | 131 | 256 | 442 | 508 |
| Tax % | 24.1% | 32.1% | 38.1% | 24.1% | 26.1% | 27.1% | 31.1% | 27.1% | 27.1% | 28.1% | — |
| Exceptional items | 0.00 | 0.00 | 4.98 | 29.87 | 16.94 | 3.98 | 0.00 | 2.99 | 1.99 | 0.00 | — |
| Net Profit | 26.99 | 52.99 | 94.08 | 176 | 117 | 97.10 | 20.99 | 95.01 | 185 | 317 | 370 |
| EPS (Rs) | 7.19 | 14.15 | 24.03 | 44.98 | 29.81 | 24.86 | 5.66 | 24.20 | 47.71 | 83.50 | 95.11 |
| Dividend payout % | 13.9% | 11.0% | 10.0% | 3.0% | 7.0% | 8.0% | 0.0% | 8.0% | 10.0% | 12.0% | — |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 38.09 | 38.09 | 39.13 | 39.08 | 39.11 | 39.12 | 39.11 | 39.14 | 39.10 | 39.10 |
| Reserves | 407 | 452 | 539 | 704 | 685 | 776 | 793 | 888 | 1,068 | 1,377 |
| Borrowings | 322 | 331 | 493 | 570 | 538 | 935 | 1,081 | 1,011 | 1,145 | 1,023 |
| Other Liabilities | 175 | 236 | 361 | 295 | 282 | 433 | 485 | 412 | 547 | 740 |
| Total Liabilities | 942 | 1,056 | 1,431 | 1,608 | 1,545 | 2,183 | 2,398 | 2,352 | 2,800 | 3,179 |
| Fixed Assets | 389 | 438 | 500 | 727 | 600 | 706 | 1,020 | 1,037 | 1,159 | 1,172 |
| CWIP | 23.98 | 49.01 | 95.03 | 39.99 | 175 | 373 | 100 | 99.04 | 141 | 314 |
| Investments | 1.01 | 3.01 | 0.00 | 1.01 | 0.00 | 12.01 | 6.99 | 39.98 | 7.99 | 54.03 |
| Other Assets | 529 | 566 | 837 | 842 | 771 | 1,092 | 1,272 | 1,174 | 1,491 | 1,639 |
| Inventories | 246 | 234 | 364 | 366 | 343 | 616 | 798 | 658 | 787 | 825 |
| Trade receivables | 175 | 231 | 332 | 268 | 240 | 266 | 297 | 349 | 395 | 527 |
| Cash & equivalents | 30.99 | 23.99 | 22.97 | 88.86 | 19.97 | 36.99 | 24.96 | 28.96 | 49.91 | 69.90 |
| Total Assets | 942 | 1,056 | 1,431 | 1,608 | 1,545 | 2,183 | 2,398 | 2,352 | 2,800 | 3,179 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 17.02 | 107 | 21.03 | 248 | 172 | 5.01 | 49.08 | 354 | 281 | 551 |
| Cash from investing activity | 80.10 | −81.01 | −139 | −206 | −242 | −321 | −133 | −180 | −294 | −359 |
| Cash from financing activity | −88.96 | −19.97 | 122 | 26.96 | 0.00 | 333 | 71.89 | −171 | 38.94 | −198 |
| Net cash flow | 6.98 | 4.98 | 3.98 | 67.76 | −68.75 | 16.95 | −11.96 | 3.98 | 25.89 | −5.98 |
| Capex | 0.00 | 0.00 | 0.00 | 211 | 243 | 310 | 140 | 151 | 299 | 320 |
| Free cash flow | 16.94 | 107 | 45.88 | 36.91 | −70.78 | −303 | −90.77 | 211 | −16.96 | 229 |
| CFO / OP % | 49.0% | 96.0% | 24.0% | 120.0% | 101.0% | 19.0% | 33.0% | 116.0% | 77.0% | 102.0% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 106 | 82 | 90 | 60 | 68 | 69 | 67 | 72 | 68 | 75 |
| Inventory days | 236 | 132 | 162 | 135 | 170 | 279 | 311 | 245 | 262 | 235 |
| Days payable | 114 | 84 | 94 | 54 | 82 | 137 | 113 | 104 | 133 | 149 |
| Cash conversion cycle | 227 | 129 | 157 | 139 | 155 | 209 | 264 | 212 | 197 | 160 |
| Working capital days | 31 | 20 | 40 | 45 | 65 | 19 | 16 | 37 | 35 | 54 |
| ROCE % | — | 13.0% | 18.0% | 20.1% | 12.0% | 10.0% | 6.0% | 12.0% | 16.0% | 22.1% |
For the Sep 2026 quarter, Privi Speciality Chemicals reported sales of ₹758 Cr, up 11.8% year on year and net profit of ₹118 Cr, up 31.1% year on year. The operating margin was 26.0%.
Privi Speciality Chemicals' sales for the year to Mar 2026 were ₹2,555 Cr; over the last twelve months they were ₹2,745 Cr.
Net profit for the year to Mar 2026 was ₹317 Cr, and ₹370 Cr over the last twelve months. Earnings per share over the same trailing period were ₹95.11.
Privi Speciality Chemicals reported borrowings of ₹1,023 Cr at Mar 2026, against cash and equivalents of ₹69.90 Cr.
Cash from operations was ₹551 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹229 Cr.